Status:
WITHDRAWN
Drug Interaction Between Ritonavir And Sitaxsentan
Lead Sponsor:
Pfizer
Conditions:
Pulmonary Arterial Hypertension
Eligibility:
All Genders
21-55 years
Phase:
PHASE1
Brief Summary
The study is to assess if sitaxsentan and ritonavir will affect the blood levels of each other when coadministered.
Eligibility Criteria
Inclusion
- Healthy male subjects and/or women of non-child bearing potential.
- Subjects (because of teratogenic risk of sitaxsentan) between the ages of 21 and 55 years, inclusive.
- Signed informed consent.
Exclusion
- Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease.
- History of significant alcohol and drug use.
- Has hepatic dysfunction.
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01251848
Start Date
January 1 2011
End Date
February 1 2011
Last Update
March 5 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.